Medibank Private Limited (ASX:MPL)
Australia · Delayed Price · Currency is AUD | Market Cap | 13.78B +4.9% |
| Revenue (ttm) | 9.30B +8.7% |
| Net Income | 638.70M +27.5% |
| EPS | 0.23 +27.5% |
| Shares Out | 2.75B |
| PE Ratio | 21.58 |
| Forward PE | 19.91 |
| Dividend | 0.19 (3.84%) |
| Ex-Dividend Date | Sep 2, 2026 |
| Volume | 906,132 |
| Open | 5.00 |
| Previous Close | 5.05 |
| Day's Range | 4.99 - 5.05 |
| 52-Week Range | 4.06 - 5.31 |
| Beta | 0.06 |
| Analysts | Hold |
| Price Target | 5.06 (+1.02%) |
| Est. Earnings | Nov 19, 2026 |
About Medibank Private
Medibank Private Limited provides private health insurance in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services comprising dental, optical, and physiotherapy, as well as offers health insurance products to overseas visitors and students. The Medibank Health segment ... [Read more]
Financial Performance
In fiscal year 2026, Medibank Private's revenue was 9.30 billion, an increase of 8.66% compared to the previous year's 8.56 billion. Earnings were 638.70 million, an increase of 27.54%.
Financial StatementsAnalyst Summary
According to 9 analysts, the average rating for MPL stock is "Hold." The 12-month stock price target is $5.06, which is an increase of 1.02% from the latest price.
News
Medibank Private Earnings Call Transcript: H2 2026
Strong operating profit growth, stable margins, and record Medibank Health results were achieved despite heightened competition and rising lapse rates. Strategic investments in direct channels, primary care, and technology underpin a positive outlook, with disciplined growth and robust capital supporting future expansion.
Medibank Private Earnings release: H2 2026
Medibank Private released its H2 2026 earnings on August 19, 2026, summarizing the period's financial results.
Medibank Private Slides: H2 2026
Medibank Private has posted slides in relation to its H2 2026 quarterly earnings report, which was published on August 19, 2026.
Medibank Private Annual report: H2 2026
Medibank Private has published its H2 2026 annual report on August 19, 2026.
Medibank Private Annual report: H2 2026
Medibank Private has published its H2 2026 annual report on August 19, 2026.
Medibank Private Earnings Call Transcript: H1 2026
Strong half-year results driven by growth in health insurance and Medibank Health, supported by the Better Medical acquisition and increased customer engagement. Stable margins, robust capital position, and a positive outlook for FY 2026 underpin continued investment and dividend growth.
Medibank Private Quarterly report: H1 2026
Medibank Private has published its H1 2026 quarterly earnings report on February 18, 2026.
Medibank Private Slides: H1 2026
Medibank Private has posted slides in relation to its H1 2026 quarterly earnings report, which was published on February 18, 2026.
Medibank Private Earnings release: H1 2026
Medibank Private released its H1 2026 earnings on February 18, 2026, summarizing the period's financial results.
Medibank Private Transcript: AGM 2025
The meeting highlighted strong financial growth, increased dividends, and major investments in mental health and primary care. Board renewal and diversity were emphasized, with new directors elected and outgoing members acknowledged. Shareholders approved all resolutions, and strategic plans target significant expansion by 2030.
Medibank Private Transcript: Status Update
Aspirations include growing health segment earnings to at least AUD 200 million by FY 2030, expanding digital and preventative care, and supporting 10 million people. Strategic investments, innovation in care delivery, and disciplined M&A underpin growth, while system transformation and stakeholder collaboration address rising healthcare demands.
Medibank Private Slides: Status Update
Medibank Private has posted slides in relation to its latest quarterly earnings report, which was published on October 28, 2025.
Medibank Private Earnings Call Transcript: H2 2025
Group operating profit rose 8.9% to $762.4 million, with strong growth in both resident and non-resident health insurance and a 27% increase in Medibank Health segment profit. Management expects stable margins, continued disciplined growth, and further M&A investment in FY 2026.
Medibank Private Annual report: H2 2025
Medibank Private has published its H2 2025 annual report on August 27, 2025.
Medibank Private Slides: H2 2025
Medibank Private has posted slides in relation to its H2 2025 quarterly earnings report, which was published on August 27, 2025.
Medibank Private Earnings release: H2 2025
Medibank Private released its H2 2025 earnings on August 27, 2025, summarizing the period's financial results.
Medibank Private Press release: Trading Update
Medibank Private issued a press release on May 5, 2025, disclosing material business information to investors.
Medibank Private Earnings Call Transcript: H1 2025
Strong financial performance driven by disciplined growth in both resident and non-resident health insurance, robust investment income, and expanding health services. Customer engagement and retention improved through value programs and digital initiatives, while capital position remains strong and M&A pipeline is healthy.
Medibank Private Quarterly report: H1 2025
Medibank Private has published its H1 2025 quarterly earnings report on February 26, 2025.
Medibank Private Slides: H1 2025
Medibank Private has posted slides in relation to its H1 2025 quarterly earnings report, which was published on February 26, 2025.
Medibank Private Earnings release: H1 2025
Medibank Private released its H1 2025 earnings on February 26, 2025, summarizing the period's financial results.
Medibank Private Transcript: AGM 2024
The AGM highlighted strong financial results, a dividend increase, and ongoing investment in digital health and sustainability. Shareholders approved all resolutions, including board expansion and fee cap increases, while management addressed concerns on technology, diversity, and cyber risk.
Medibank: Australian healthcare pivoting to homebased and preventative care
David Koczkar, CEO of Medibank discusses the shifting Australian healthcare landscape and the health insurer's focus on innovation investment.
Medibank Private Earnings Call Transcript: H2 2024
Solid FY 2024 results with strong profit growth, disciplined market share strategy, and robust capital position. Continued investment in health services, digital innovation, and M&A supports long-term growth, while customer givebacks and productivity savings remain priorities.
Medibank Private Annual report: H2 2024
Medibank Private has published its H2 2024 annual report on August 21, 2024.